• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区获得性肺炎患者中皮质类固醇的使用、心肌损伤和院内心血管事件。

Corticosteroid use, myocardial injury and in-hospital cardiovascular events in patients with community-acquired pneumonia.

机构信息

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.

出版信息

Br J Clin Pharmacol. 2022 Jan;88(1):155-165. doi: 10.1111/bcp.14936. Epub 2021 Jul 22.

DOI:10.1111/bcp.14936
PMID:34087003
Abstract

BACKGROUND AND PURPOSE

Corticosteroids are often prescribed to community-acquired pneumonia (CAP) patients, but the relationship with major cardiovascular events (MACEs) is unclear.

EXPERIMENTAL APPROACH

541 CAP patients were recruited (334 males, mean age 71.9 ± 16.2 years). High-sensitivity troponin T (hs-cTnT) was measured at admission, during the hospital stay and at discharge. MACE occurrence was registered during a long-term follow-up.

KEY RESULTS

Overall, 318 patients (59%) showed hs-cTnT elevation >99th percentile (>0.014 μg/L). Age, heart failure and the increasing quintiles of hs-cTnT (hazard ratio [HR] 2.16, 95% confidence interval [CI] 1.82-2.58, P < .001) predicted MACEs. Among patients with hs-cTnT >0.014 μg/L at admission, 102 patients (31%) were on corticosteroids and showed lower hs-cTnT increase (P = .021), (NADPH) oxidase-2 (Nox2) activation (P = .005) and incidence of MACEs than untreated ones (HR 0.64, 95% CI 0.41-0.97, P = .038); no effect of corticosteroids on MACEs was observed in CAP patients with normal troponin. In vitro study showed that glucocorticoids have an antioxidant effect via downregulation of Nox2 activity.

CONCLUSION AND IMPLICATIONS

The study provides evidence that corticosteroid use is associated with lower increase of hs-cTnT and incidence of MACEs in CAP patients.

摘要

背景与目的

皮质类固醇常被用于治疗社区获得性肺炎(CAP)患者,但与主要心血管事件(MACE)的关系尚不清楚。

实验方法

共招募了 541 名 CAP 患者(334 名男性,平均年龄 71.9±16.2 岁)。入院时、住院期间和出院时检测高敏肌钙蛋白 T(hs-cTnT)。在长期随访期间登记 MACE 发生情况。

主要结果

总体而言,318 名患者(59%)hs-cTnT 升高超过第 99 百分位数(>0.014μg/L)。年龄、心力衰竭和 hs-cTnT 递增五分位(风险比 [HR] 2.16,95%置信区间 [CI] 1.82-2.58,P<0.001)预测 MACE。入院时 hs-cTnT >0.014μg/L 的患者中,有 102 名(31%)正在使用皮质类固醇,hs-cTnT 升高幅度较低(P=0.021),(NADPH)氧化酶-2(Nox2)激活(P=0.005),MACE 发生率低于未治疗者(HR 0.64,95%CI 0.41-0.97,P=0.038);在肌钙蛋白正常的 CAP 患者中,皮质类固醇对 MACE 无影响。体外研究表明,糖皮质激素通过下调 Nox2 活性具有抗氧化作用。

结论和意义

本研究表明,皮质类固醇的使用与 CAP 患者 hs-cTnT 升高幅度降低和 MACE 发生率降低相关。

相似文献

1
Corticosteroid use, myocardial injury and in-hospital cardiovascular events in patients with community-acquired pneumonia.社区获得性肺炎患者中皮质类固醇的使用、心肌损伤和院内心血管事件。
Br J Clin Pharmacol. 2022 Jan;88(1):155-165. doi: 10.1111/bcp.14936. Epub 2021 Jul 22.
2
Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial.皮质类固醇对社区获得性肺炎住院患者心肌损伤的影响:理论依据与研究设计。罗马斗兽场试验。
Intern Emerg Med. 2020 Jan;15(1):79-86. doi: 10.1007/s11739-019-02117-0. Epub 2019 May 31.
3
Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia?Nox2上调与肺炎患者的心肌损伤有关吗?
Antioxid Redox Signal. 2014 Jun 20;20(18):2949-54. doi: 10.1089/ars.2013.5766. Epub 2014 Mar 14.
4
Artificial intelligence-augmented electrocardiography for left ventricular systolic dysfunction in patients undergoing high-sensitivity cardiac troponin T.人工智能增强心电图在高敏心肌肌钙蛋白 T 检测患者左心室收缩功能障碍中的应用。
Eur Heart J Acute Cardiovasc Care. 2023 Feb 9;12(2):106-114. doi: 10.1093/ehjacc/zuac156.
5
Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy.联合评估冠状动脉疾病和高敏心肌肌钙蛋白 T 对肥厚型心肌病患者不良事件的预测价值。
BMC Cardiovasc Disord. 2021 Jul 3;21(1):325. doi: 10.1186/s12872-021-02135-x.
6
Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort.美国多中心队列中高敏心肌肌钙蛋白T检测策略与临床变量的诊断效能
Circulation. 2021 Apr 27;143(17):1659-1672. doi: 10.1161/CIRCULATIONAHA.120.049298. Epub 2021 Jan 21.
7
High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia.高敏心肌肌钙蛋白 T 可预测社区获得性肺炎住院后的死亡率。
Respirology. 2017 Jul;22(5):1000-1006. doi: 10.1111/resp.12996. Epub 2017 Feb 21.
8
Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.高敏心肌肌钙蛋白 T 在肥厚型心肌病中的意义。
J Am Coll Cardiol. 2013 Oct 1;62(14):1252-1259. doi: 10.1016/j.jacc.2013.03.055. Epub 2013 Apr 23.
9
The prognostic value of high sensitivity cardiac troponin T in patients with congenital heart disease.高敏心肌肌钙蛋白T在先天性心脏病患者中的预后价值。
J Cardiol. 2018 Apr;71(4):389-393. doi: 10.1016/j.jjcc.2017.09.012. Epub 2017 Nov 3.
10
Cardiac Troponin and Recurrent Major Vascular Events after Minor Stroke or Transient Ischemic Attack.轻微卒中或短暂性脑缺血发作后心肌肌钙蛋白与复发性重大血管事件
Ann Neurol. 2021 Dec;90(6):901-912. doi: 10.1002/ana.26225. Epub 2021 Oct 11.

引用本文的文献

1
A Multicentric Observational Study to Determine Myocardial Injury in Severe Community-Acquired Pneumonia (sCAP).一项多中心观察性研究,以确定重症社区获得性肺炎(sCAP)中的心肌损伤。
Antibiotics (Basel). 2023 Dec 8;12(12):1710. doi: 10.3390/antibiotics12121710.
2
Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.COVID-19 住院患者接受甲泼尼龙治疗后的细胞因子和损伤生物标志物的时间模式。
Front Immunol. 2023 Aug 16;14:1229611. doi: 10.3389/fimmu.2023.1229611. eCollection 2023.
3
Recent Advances in Nanomaterials for Asthma Treatment.
纳米材料在哮喘治疗中的最新进展。
Int J Mol Sci. 2022 Nov 20;23(22):14427. doi: 10.3390/ijms232214427.
4
Berberine-Loaded Biomimetic Nanoparticles Attenuate Inflammation of Experimental Allergic Asthma Enhancing IL-12 Expression.载有小檗碱的仿生纳米颗粒通过增强白细胞介素-12表达减轻实验性过敏性哮喘的炎症。
Front Pharmacol. 2021 Nov 9;12:724525. doi: 10.3389/fphar.2021.724525. eCollection 2021.